Global Intravenous Iron Drugs Market Size & Outlook
Global intravenous iron drugs market, 2018-2030 (US$M)
Related Markets
Global intravenous iron drugs market highlights
- The global intravenous iron drugs market generated a revenue of USD 3,026.4 million in 2023 and is expected to reach USD 5,620.2 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 9.2% by 2030.
- In terms of segment, ferric carboxymaltose accounted for a revenue of USD 1,520.0 million in 2023.
- Ferric Carboxymaltose is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 3,026.4 million |
| Market revenue in 2030 | USD 5,620.2 million |
| Growth rate | 9.2% (CAGR from 2023 to 2030) |
| Largest segment | Ferric carboxymaltose |
| Fastest growing segment | Ferric Carboxymaltose |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Iron Dextran, Iron Sucrose, Ferric Carboxymaltose |
Other key industry trends
- In terms of revenue, the North America accounted for 50.7% of the global intravenous iron drugs market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 2,393.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravenous Iron Drugs Market Scope
Intravenous Iron Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global intravenous iron drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous iron drugs market will help companies and investors design strategic landscapes.
Ferric carboxymaltose was the largest segment with a revenue share of 50.22% in 2023. Horizon Databook has segmented the Global intravenous iron drugs market based on iron dextran, iron sucrose, ferric carboxymaltose covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Intravenous Iron Drugs Product Outlook (Revenue, USD Million, 2018-2030)
- Iron Dextran
- Iron Sucrose
- Ferric Carboxymaltose
- Others
- Global Intravenous Iron Drugs Application Outlook (Revenue, USD Million, 2018-2030)
- Chronic Kidney Disease
- Inflammatory Bowel Disease
- Cancer
- Other Diseases
Reasons to subscribe to Global intravenous iron drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global intravenous iron drugs market databook
-
Our clientele includes a mix of intravenous iron drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global intravenous iron drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global intravenous iron drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global intravenous iron drugs market size, by regions, 2018-2030 (US$M)
Top 10 countries: Intravenous iron drugs market size, 2023 (US$M)
Global intravenous iron drugs market share, by product, 2023 & 2030 (%, US$M)
Intravenous iron drugs market: Opportunity assessment by country
Global intravenous iron drugs market, by region, 2023 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
